| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Interim CFO | EVP And CFO
2 companies
Frost Mark T is a Chief Financial Officer at Harvard Bioscience, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $755K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | HBIO Harvard Bioscience, Inc. | Chief Financial Officer | Buy | 5,000 | $5.00 | $25,000.00 | +40.0% | - | - |